SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-18-023694
Filing Date
2018-09-28
Accepted
2018-09-28 16:07:45
Documents
56
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 6-K arct-6k_20180630.htm 6-K 28754
2 EX-99.1 arct-ex991.htm EX-99 903157
3 EX-99.2 arct-ex992.htm EX-99 273532
  Complete submission text file 0001564590-18-023694.txt   4773711

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arct-20180630.xml EX-101.INS 1063119
5 XBRL INSTANCE DOCUMENT arct-20180630.xsd EX-101.SCH 39412
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arct-20180630_cal.xml EX-101.CAL 41161
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arct-20180630_def.xml EX-101.DEF 101175
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20180630_lab.xml EX-101.LAB 281169
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20180630_pre.xml EX-101.PRE 209696
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35932 | Film No.: 181094240
SIC: 2834 Pharmaceutical Preparations